|Articles|October 7, 2020

High Throughput DAR Determination of Brentuximab Vedotin

YMC’s latest HIC column is used to analyse the DAR of Brentuximab Vedotin allowing higher flow rates and shorter run times thanks to the pressure resistant particle.

Newsletter

Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.

Subscribe Now!

Related Content

In-Depth Characterization of Canonical ADC Platforms by HIC (Dec 2025)

ByTosoh Bioscience

December 3rd 2025

BioCore HIC Column Family：A Unique Tool for Protein-based Biotherapeutics Analysis

ByNanoChrom Technologies (Suzhou) Co., Ltd

November 13th 2025

Analysis of 40 Per- and Polyfluoroalkyl Substances by US EPA Method 1633 Part 4: Application to Fish and Other Animal Tissue Samples

ByPerkinElmer, Inc.

November 12th 2025

Analysis of 40 Per- and Polyfluoroalkyl Substances by US EPA Method 1633 Part 3: Application to Sand, Soil, Sediment, Sludge, Biosolid and Other Solid Samples

ByPerkinElmer, Inc.

November 12th 2025

Analysis of 40 Per- and Polyfluoroalkyl Substances by US EPA Method 1633 Part 2: Application to Surface Water and Wastewater Samples

ByPerkinElmer, Inc.

November 12th 2025

High Throughput DAR Determination of Brentuximab Vedotin

Newsletter

Related Content

In-Depth Characterization of Canonical ADC Platforms by HIC (Dec 2025)

BioCore HIC Column Family：A Unique Tool for Protein-based Biotherapeutics Analysis

Analysis of 40 Per- and Polyfluoroalkyl Substances by US EPA Method 1633 Part 4: Application to Fish and Other Animal Tissue Samples

Analysis of 40 Per- and Polyfluoroalkyl Substances by US EPA Method 1633 Part 3: Application to Sand, Soil, Sediment, Sludge, Biosolid and Other Solid Samples

Analysis of 40 Per- and Polyfluoroalkyl Substances by US EPA Method 1633 Part 2: Application to Surface Water and Wastewater Samples

Trending on LCGC International

Navigating Adverse Reactions in GLP-1 Treatment

Decoding Sweet Potato Drought Resilience: Metabolomic Evidence from UPLC-MS Profiling

Toward Safer Diabetes Devices: GC–MS Detection of Allergens in Sensors, Pumps, and Infusion Sets

Shifting GLP-1 Receptor Agonists from Proteins to Small Molecules

Advancing RNA-Based Therapeutics: IQ Consortium Experts on Optimizing Chromatographic Bioanalysis